What are the side effects of Magnesium Glycinate?

Diarrhea, nausea, or abdominal cramping (dose-dependent; less than oxide or citrate)

Who should avoid Magnesium Glycinate?

Kidney impairment or chronic kidney disease without medical supervision (risk of magnesium build-up) Heart block or bradycardia at high intakes without review

Mineral

Magnesium Glycinate

A well-absorbed, low-laxative form of an essential mineral, used as an evening calm/sleep foundation. Its human evidence for sleep and stress is real but modest and concentrated in people who are low to begin with: a mild, mainly-if-you're-deficient effect, not a sedative. This is the everyday repletion form; the CNS-targeted cognition pitch belongs to magnesium L-threonate, a different form graded C on small, commercially funded trials.

Grade CUpdated September 17, 2026Written and fact-checked in-house against The Evidence Standard. Not a clinical review.

Photo by Engin Akyurt on Pexels

Please note

Educational content, not medical advice. Doses below are ranges used in research, not recommendations. Talk to a qualified clinician before starting any supplement, especially if you take medication, are pregnant, or manage a health condition.

Evidence grade: Evidence: Grade C
Studied dose range: ~200–350 mg elemental magnesium/day (the key sleep RCT used 250 mg). Watch the compound-weight trap: bisglycinate is only ~14% elemental magnesium, so ~250 mg elemental is ~1,800 mg of the salt. Studies and labels must state elemental. The supplemental upper limit is 350 mg/day elemental (food magnesium is not counted).
Time to effect: Not acute; sleep/stress benefits in trials appeared over roughly 1–4 weeks of daily use.
Best form: Magnesium bisglycinate (glycinate): better GI tolerance and far less laxative effect than magnesium oxide. For a cognition-specific claim, magnesium L-threonate is the differentiated form, but its evidence is Grade C: the positive trials are small and commercially funded, and a publicly funded trial found no significant sleep or cognitive benefit.

The short answer

Magnesium Glycinate (Mineral) is studied for sleep-onset support (evening use) and stress and relaxation. In our conservative reading of the published human research, the evidence is Grade C (limited). ~200–350 mg elemental magnesium/day (the key sleep RCT used 250 mg). Watch the compound-weight trap: bisglycinate is only ~14% elemental magnesium, so ~250 mg elemental is ~1,800 mg of the salt. Studies and labels must state elemental. The supplemental upper limit is 350 mg/day elemental (food magnesium is not counted). Not acute; sleep/stress benefits in trials appeared over roughly 1–4 weeks of daily use. A studied dose is what trials used, not a recommended dose.

Full profile

Also known as	Magnesium bisglycinate, Chelated magnesium
Best for	Sleep-onset support (evening use) · Stress and relaxation · Gentle magnesium repletion in a non-laxative form
Evidence grade	Grade C · Limited: early or small human trials
Studied dose range	~200–350 mg elemental magnesium/day (the key sleep RCT used 250 mg). Watch the compound-weight trap: bisglycinate is only ~14% elemental magnesium, so ~250 mg elemental is ~1,800 mg of the salt. Studies and labels must state elemental. The supplemental upper limit is 350 mg/day elemental (food magnesium is not counted).
Time to effect	Not acute; sleep/stress benefits in trials appeared over roughly 1–4 weeks of daily use.
Best form	Magnesium bisglycinate (glycinate): better GI tolerance and far less laxative effect than magnesium oxide. For a cognition-specific claim, magnesium L-threonate is the differentiated form, but its evidence is Grade C: the positive trials are small and commercially funded, and a publicly funded trial found no significant sleep or cognitive benefit.
Food sources	Leafy greens, Nuts and seeds (pumpkin, almonds), Legumes, Whole grains, Dark chocolate

Evidence, honestly graded

Limited but real. A 2025 RCT of magnesium bisglycinate in adults with poor sleep (Schuster 2025, n=155) found a statistically significant but small reduction in insomnia severity (larger in people with low dietary intake), and one author is tied to a nutraceutical-funded CRO, so it is sponsor-adjacent. A meta-analysis of oral magnesium for insomnia in older adults (Mah 2021) found sleep onset roughly 17 minutes shorter than placebo but rated the evidence low-to-very-low quality, and a systematic review of magnesium for anxiety/stress (Boyle 2017) found only a suggestive benefit in anxiety-prone groups on poor-quality trials. Reviewed 2026-09-17 against a systematic review of every randomized trial of magnesium as a stand-alone sleep intervention (Lopresti 2026, 12 trials): findings were inconsistent across subjective scales, EEG, actigraphy and wearables, certainty was low to very low, and the authors conclude the evidence does not support magnesium as a routine treatment for insomnia. Graded C. General-magnesium cognition evidence is weaker still. The crisp line versus L-threonate is claim architecture, not magnesium content.

See the full grading rubric (study type, replication, population match, and dose adequacy) in The Evidence Standard.

Side effects

Diarrhea, nausea, or abdominal cramping (dose-dependent; less than oxide or citrate)

Who should avoid it or check first

Kidney impairment or chronic kidney disease without medical supervision (risk of magnesium build-up)
Heart block or bradycardia at high intakes without review

Interactions

Reduces absorption of oral bisphosphonates, tetracycline and quinolone antibiotics, and levothyroxine; separate doses by a few hours
PPIs and loop/thiazide diuretics alter magnesium status; discuss with a clinician

Stacks well with

Glycine (evening slot)
Melatonin (evening slot)

Use caution stacking with

Daytime stimulant-free focus actives (this is an evening ingredient)

What to look for on a label

Declare elemental magnesium, not compound weight. Health Canada specifically flags magnesium for dosing-error risk.
Honest regulatory note: Health Canada's multi-vitamin/mineral monograph does NOT permit sleep, stress, or cognition claims for magnesium, only structural/functional ones (e.g. normal nervous-system and muscle function). A sleep/calm positioning needs its own product-specific evidence dossier. Products above 350 mg/day elemental must carry a "may experience diarrhea" statement.

References

Lopresti AL, Smith SJ, Drummond PD (2026). Journal of Dietary Supplements, 23(5):553–581GRADE-assessed systematic review, 12 randomized trials of magnesium as the only active interventionResults were inconsistent across subjective scales, EEG, actigraphy and consumer wearables; certainty of evidence was low to very low, and the review concludes magnesium is not supported as a routine treatment for insomnia.
Schuster J, Cycelskij I, Lopresti A, Hahn A (2025). Nature and Science of Sleep, 17:2027–2040RCT, n=155 adults with poor sleep, 4 weeksStudied dose: 250 mg elemental magnesium (bisglycinate)Small but significant reduction in insomnia severity versus placebo; larger in people with low dietary magnesium.
Mah J, Pitre T (2021). BMC Complementary Medicine and Therapies, 21(1):125Systematic review and meta-analysis, 3 RCTs, n=151Modest reduction in sleep-onset latency on a low-quality evidence base.
Boyle NB, Lawton C, Dye L (2017). Nutrients, 9(5):429Systematic review, 18 studiesSuggestive reduction in subjective anxiety in vulnerable groups only; low-quality evidence.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

Revision history

Every change to this ingredient's evidence status, dated and explained. The full cross-library log lives at Evidence Updates.

2026-10-12Citation review
Separated the one bisglycinate sleep trial from the meta-analysis we cited, which pooled other forms of magnesium in older adults. That sleep-onset estimate is not specific to glycinate. C holds.
2026-09-17Citation review
Added a 2026 systematic review of every randomized trial of magnesium as a stand-alone sleep intervention: results were inconsistent across subjective scales, EEG, actigraphy and wearables, certainty was low to very low, and the review concludes magnesium is not supported as a routine treatment for insomnia. C holds, on firmer ground than before.
2026-07-12New profile
New profile at Grade C — a well-tolerated, well-absorbed magnesium form with limited direct human cognition/sleep trials at this specific form.

See how Magnesium Glycinate compares on grade, dose, and goal in the Evidence Explorer.

Less noise. More signal.

Get The Signal by email

New research write-ups, evidence-grade changes and safety notes, about every two weeks. Free, with the Clean Focus Stack Guide when you join, and first word if Signal State Core launches.

About every two weeksFree guide on signupUnsubscribe anytime